New Zealanders' access to safe and affordable medicines could be limited under a massive trade deal being secretly negotiated, opposition parties say.

Alarm at the provisions of a leaked draft of the investment chapter of the Trans-Pacific Partnership agreement is premature to say the least, says Stephen Jacobi.

When her father was diagnosed with terminal cancer in November, Abbey Looker decided she couldn't walk down the aisle with anyone but him.

A teenager with a life-threatening illness has had a "miracle" response to a drug Pharmac said it wouldn't fund.

Despite being born only two minutes apart, Axel is considerably smaller than his twin brother, and has a raft of significant health problems to boot.

Obesity might be a risk factor for gout, but new research has suggested that being overweight doesn't make the condition any worse.

The cost of new "generic" versions of Herceptin and other such pharmaceuticals looks likely to become a casualty of the TPP agreement, writes George Laking.

Andrea Murphy says her life has been saved from a killer blood disease by an expensive "miracle" drug and is pleading for Pharmac to approve state funding of it.

Leaked proposed provisions of the Trans Pacific Partnership Agreement could affect our ability to treat chronic diseases, writes Briar Mannering.

It is not a binary question - will Pharmac survive or not? - but rather how might the rules it operates under change, writes Brian Fallow.

Researchers have issued a new caution over the use of Champix quit-smoking tablets.

Labour's Phil Goff says the US doesn't have the negotiating strength to impose its will on NZ and weakening Pharmac is something only big pharmaceutical companies want.